Abstract
Intraarterial administration of chemotherapy results in augmentation of both local peak plasma concentration of the drug and local area under the concentration - times - time curve (AUC) during the drug infusion (1–4). It can be particularly advantageous to administer drugs with a rapid total body clearance intraarterially since if clearance is rapid, the usual AUC will be relatively small, and the local increase in AUC resulting from intraarterial administration will be proportionally quite large (3, 4). For some drugs, intraarterial administration would be expected to result in increased therapeutic efficacy, while for other drugs, there would be relatively little advantage (1–4). Augmentation of local tissue concentrations by intraarterial administration has been documented for some drugs (5–9), but not for others (10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fenstermacher (J.D.), Cowles (A.K.).Theoretic limitations of intracarotid infusions in brain tumor chemothe-1980.
Chen (H-SG), Gross (J.F.). Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31–40 (1980).
Collins (J.) Pharmacologic rationale for regional drug delivery. J. Clin Oncol 2: 498–504 (1984).
Ensminger (W.), Gyves (J.). Clinical pharmacology of hepatic arterial chemotherapy. Semin. Oncol. 10: 176–182 (1983).
Stewart (D.J.), Leavens (M.), Maor (M.), Feun (L.), Luna (M.), Bonura (J.), Caprioli (R.), Loo (T.L.), Benjamin (R.S.): Human central nervous system distribution of Cis-Diaminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Research 42: 2474–2479 (1982).
Stewart (D.J), Mikhael (N.), Nanji (A.), Kacew (S.), Maroun (J.), HIRTE W: Human tissue cisplatin (CP) pharmacology: clinical implications. Proc Amer Assoc Cancer Res 26: 154 (1985).
Levin (V.A.), Kabra (P.M.), Freeman-Dove (M.A.). Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. Neurosurgery 48: 587–593 (1978).
Carlson (J.A. Jr.), Litterst (C.L.), Greenberg (R.A.), Day (T.G. Jr.), Masterson (B.J.). Platinum tissue concentrations following intra-arterial and intravenous cis-diamine-dichloroplatinum II in New Zealand white rabbits. Am J Obstet Gynecol 148: 313–317 (1984).
Stewart (D.J.), Novel modes of chemotherapy administration. in: Rosenblum (M.L.), Wilson (C.B.) (eds). Progress in experimental brain tumor research (S. Kargel Med & Scientific Publishers. Basel/Switzerland, 1984) 28: 32–50.
Madajewicz (S.), Spaulding (M.), Bhimani (S.), Avellanosa (A.), De Los Santos (R.), Perry (A.), Zeigler (P.), Kirshner (J.). Phase I-II Diaziquone chemotherapy in brain tumors. Cancer Treat Rep 68: 913–914 (1984).
Bonstelle (C.T.), Kori (S.H.), Rekate (H.). Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption. AJNR 4: 810–812 (1983).
Feun (L.G.), Lee (Y.-Y.), Yung (W.K.A.), Charnsangavej (C.), Savaraj (N.), Tang (R.A.), Wallace (S.). Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Cancer Drug Delivery 3: 147–156 (1986).
Yamashita (J.), Handa (H.), Tokuriki (Y.), Ha (Y.S.), Otsuka (S.-I), Suda (K.), Taki (W.). Intra-arterial ACNU therapy for malignant brain tumors: experimental studies and preliminary clinical results. J. Neurosurg 59: 424–430 (1983).
Bremer (A.M.), Kleriga (E.), Nguyen (E.), Balsys (R.), Northup (H.M.), Gonzalez (N.), Duarte (P.), Miller (R.I.). Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors. J. Neuro-Oncol 2: 129–132 (1984).
Calvo (F.A.), Pastor (M.A.), Dy (C.), Algeria (E.), Aparicio (L.M.A.), Gil (A.), Harguindey (S.), Zubieta (J.L.), Lage (M.M.). Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma: preliminary results. Am J. Clin Oncol (CLT) 8: 200–209 (1985).
Stewart (D.J.), Grahovac (Z.), Gupta (S.) Goumnerova (L.), Richard (M.), Hugenholtz (H.), Maroun (J.): Phase I study of intracarotid PCNU. J Neuro-Oncol 4: 114 (1986).
Feun (L.G.). Intra-arterial chemotherapy for primary and metastatic brain cancer: Cancer Bulletin 36: 57–61 (1984).
Greenberg (H.S.), Ensminger (W.), Layton (P.), Gebarski (S.), Meyer (M.B.), Bender (J.), Grillo-Lopez (A.). A phase I-II evaluation of intra-arterial diaziquone (AZQ) for malignant tumors of the central nervous system. Proc Am Soc Clin Oncol 3: 256 (1984).
West (C.R.), Avellanosa (A.M.), Barua (N.R.), Patel (A.R.). Phase II study of intra-arterial (IA) BCNU plus VM-26 for malignant gliomas and for metastatic brain tumors. Proc Am Soc Clin Oncol 2: 234 (1983).
Mughal (T.), Glode (L.M.), Braun (T.J.), Geyer (M.), Kindt (G.). Phase I study of intra-arterial bis-chloroethyl nitrosourea and 2′-deoxy-5-fluoridine in malignant astrocytomas. Proc Am Assoc Cancer Res 25: 198 (1984).
Stewart (D.J.), Grahovac (Z.), Benoit (B.), Addison (D.), Richard (M.T.), Dennery (J.), Hugenholtz (H.), Russell (N.), Peterson (E.), Maroun (J.A.), Vandenberg (T.), Hopkins (H.S.). Intracarotid chemotherapy with a combination of 1, 3-Bis (2-chloroethyl)-1-nitrosourea (BCNU), cis-Diaminedichloroplatinum (Cisplatin) and 4’-O-Demethyl-l-0 (4, 6-0-2-thenylidene-β-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurg 15: 828–833 (1984).
Stewart (D.J.), Wallace (S.), Feun (L.), Leavens (M.), Young (S.E.), Handel (S.), Mavligit (G.), Benjamin (R.S.). Intracarotid artery infusion of Cis-Diaminedichloroplatinum: phase I study in patients with recurrent malignant intracerebral tumors. Cancer Res 42: 2059–2062 (1982).
Feun (L.G.), Wallace (S.), Stewart (D.J.), Chuang (V.P.), Yung (W-KA), Leavens (M.E.), Burgess (M.A.), Savaraj (N.), Benjamin (R.S.), Young (S.E.), Tang (R.A.), Handel (S.), Mavligit (G.), Fields (W.S.). Intracarotid infusion of Cis-Diaminedichloroplatinum in the treatment of recurrent malignant tumors. Cancer 54: 794–799 (1984).
Madajewicz (S.), West (C.R.), Park (H.C.), Avellanosa (A.M.), Caracandas (J.E.), Takita (H.), Vincent (R.G.), Jennings (E.). Phase II study of intra-arterial 4’-0-demethyl-1-0-(4,6-0-2-thynylidene-β-D-glycopyranosyl) epipodophyllotoxin (VM-26) therapy of metastic bronchogenic adenocarcinoma to the brain. Proc Am Soc Clin Oncol 22: 502 (1981).
Madajewicz (S.), West (C.R.), Park (H.C.), Ghoorah (J.), Avellanosa (A.M.), Takita (H.), Karakousis (C.), Vincent (R.), Caracandas (J.), Jennings (E.). Phase II study - intraarterial BCNU therapy for metastatic brain tumors. Cancer 47: 653–657 (1981).
Drewinko (B.), Gottleib (J.). Action of cis-dichlorodiamineplatinum (II) (NSC-119875) at the cellular level. Cancer Chemother Rep 59: 665–673 (1975).
Issell (B.). The podophyllotoxin-derivatives VP-16-213 and VM-26. Cancer Chemother Pharmacol 7: 73–80 (1982).
Dewayne (R.), Peck (C.), Hilliard (S.), Karas (J.). Response of L1210 leukemia to treatment with 1, 3-bis (2-chloroethyl)-1-nitrosourea plus 4’-demethylepipodophyllotoxin-9-(4, 6-0-2-thenylidene-β-D-glucopyranoside). Cancer Res 41: 3891–3895 (1981).
Stewart (D.J.), Grahovac (Z.), Hugenholtz (H.), Benoit (B.), Richard (M.). Russell (N.), Maroun (J.), Dennery (J.), Peterson (E.), Nabwangu (J.). Intraarterial plus systemic chemotherapy in the treatment of intracerebral tumors. J. Neuro-Oncol 4: 114 (1986).
Djerassi (I.), Sun Kim (J.), Shulman (K.). High-dose methotrexate-citrovorum factor rescue in the management of brain tumors. Cancer Treat Rep 61: 691–694 (1977).
Rosenstock (J.G.), Evans (E.), Schut (L.). Response to vincristine of recurrent brain tumors in children. J. Neurosurg 45: 135–140 (1976).
Takeuchi (K.). A clinical trial of intravenous bleomycin in the treatment of brain tumors. Int J. Clin Pharmacol 12: 419–426 (1975).
Kumar (A.), Renaudin (J.), Wilson (C.), Boldrey (E.), Enot (K.), Levin (V.). Procarbazine hydrochloride in the treatment of brain tumors. J. Neurosurg 40: 365–371 (1974).
Sklansky (B.), Mann-Kaplan (R.), Reynolds (A.), Rosenblum (M.), Walker (M.). 4’-Demethyl-epipodophyllotoxin-β-D-thenylidene-glucoside (PTG) in treatment of malignant intracranial neoplasms. Cancer 33: 460–467 (1974).
Barraneo (S.), Kue (J.), Romsdahl (M.), Humphrey (R.). Bleomycin as a possible synchronizing agent for human tumor cells in vivo. Cancer Res 33: 882–887 (1973).
Chello (P.), Sirotvak (F.), Dorick (D.), Moccio (D.). Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia. Cancer Treat Rep 63: 1889–1894 (1974).
Stewart (D.J.), Richard (M.T.), Hugenholtz (H.), Dennery (J.), Nundy (D.), Prior (J.), Montpetit (V.), Hopkins (H.S.). Penetration of teniposide (VM-26) into human intracerebral tumors : preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with Amphotericin-B or oral glycerol. J. Neuro-Oncol 2: 315–324 (1984).
Lehane (D.E.), Bryan (R.N.), Horowitz (B.), De Santos (L.), Ehni (G.), Zubler (M.A.), Moiel (R.), Rudolph (L.), Aldama-Leubbert (A.), Mahoney (D.), Harper (R.). Intraarterial cisplatinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug Delivery 1: 69–77 (1983).
Bergerat (J.P.), Drewinko (B.), Corry (P.), Barlogie (B.), Ho (D.H.). Synergistic lethal effect of cis-dichlorodiamineplatinum and 1-β-D-arabinofuranosylcytosine. Cancer Res 41: 25–30 (1981).
Kyriazis (A.P.), Kyriazis (A.A.), Martelo (A.J.). Response to single agent and combination chemotherapy of a human pancreatic carcinoma grown in nude mice. Proc Am Assoc Cancer Res 22: 211 (1981).
Schabel (F.M.) Jr, Laster (W.R.) Jr, Trader (M.W.), Corbett (T.H.), Griswold (D.P.) Jr. Combination chemotherapy with nitrosoureas plus other anticancer drugs against animal tumors. in : Prestayko (A.W.), Crooke (A.T.), Baker (L.H.), Carter (S.K.), Schein (P.S.), (eds). Nitrosoureas: Current Status and New Developments. (Academic Press, New York, New York, 1981): 9–26.
Opfell (R.), Muggia (F.). The role of VM-26 (teniposide: NSC 122819) in chemotherapy of cancer. Chemoterapia 1: 98–101 (1982).
Boghdan (U.). Chemosensitivity of malignant brain tumors: preliminary results. J. Neuro-Oncol 1: 149–166 (1983).
Stewart (D.J.), O’Bryan (M.), Al-Sarraf (M.), Costanzi (J.J.), Oishi (N.). Phase II study of cisplatin in recurrent astrocytomas in adults. J. Neuro-Oncol 1: 145–147 (1983).
Stewart (D.J.), Richard (M.), Hugenholtz (H.N.), Benoit (B.), Russel (N.), Dennery (J.), Peterson (E.), Maroun (J.A.). Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J. Neuro-Oncol 2: 29–34 (1984).
Meyer (J.), Fukuuchi (Y.), Shimazu (K), Mathew (N.), Ohuchi (T.). Effect on regional cerebral blood flow of compression by a mass lesion. Europ Neurol 8: 83–91 (1972).
Villemure (J.G.), personal communication.
Stewart (D.J.), Grahovac (Z.), Richard (M.T.), Benoit (B.), Maroun (J.A.), Hugenholtz (H.), Russel (N.), Dennery (J.), Peterson (E.), Luke (B.), Ventureya (E.G.), Girard (A.), Hopkins (H.S.). Phase i study of intraarterial mitomycin-c for recurrent intracerebral tumors. in: Walker (M.), Thomas (D.) (eds) Biology of Brain Tumor (Martinus Nijhoff Publishers, Dordrecht, The Netherlands) (1986): pp. 469–474.
Stewart (D.J.), Grahovac (Z.), Maroun (J.), Hugenholtz (H.), Benoit (B.), Richard (M.), Russel (N.), Dennery (J.), Peterson (E.), Luke (B.), Hopkins (H.). Intraarterial (IA) chemotherapy (CT) for brain tumors (BT). Proc Amer Soc Clin Oncol 4: 132 (1985).
Misra (N.C.), Jaiswal (M.), Singh (R.), Das (B.). Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in the treatment of primary and metastatic liver carcinoma. Cancer 39: 1425–1429 (1977).
Takakura (K.). Chemotherapy of metastatic brain tumors with particular reference to continuous intracranial infusion of mitomycin-C and a radiosensitizing agent BUDR. Jpn J. Cancer Clin 17: 263–268 (1971).
Stewart (D.J), Grahovac (Z.), Riding (M.), Gupta (S.), Hugenholtz (H.), Da Silva (V.), Richard (M.), Benoit (B.), Russel (N.), Maroun (J.), Verma (S.). Intracarotid (IC) PCNU: an NCI Canada study. Proc Am Soc Clin Oncol 5: 136 (1986).
Stewart (D.J.), Benjamin (R.S.), Leavens (M.), Valdivieso (M.), Burgess (M.A.), Bodey (G.P.). Phase I study of intravenous 1-(2-Chloroethyl)-3-(2, 6-Dioxo-3-Piperidyl)-l-Nitrosourea (PCNU, NSC 95466) in adults with solid tumors. Cancer Res 40: 3750–3754 (1980).
Feun (L.G.), Stewart (D.J.), Leavens (M.E.), Burgess (M.A.), Savaraj (N.), Benjamin (R.S.), Bodey (G.P). A phase II trial of 1-(2-Chloroethyl)-3-(2, 6-Dioxo-3-Piperidyl)-1-Nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. J. Neuro-Oncol 1: 45–48 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Stewart, D.J. (1987). Intraarterial Chemotherapy for Brain Tumors: A Summary of the Ottawa Experience. In: Chatel, M., Darcel, F., Pecker, J. (eds) Brain Oncology Biology, diagnosis and therapy. Developments in Oncology, vol 52. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3347-7_72
Download citation
DOI: https://doi.org/10.1007/978-94-009-3347-7_72
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8003-3
Online ISBN: 978-94-009-3347-7
eBook Packages: Springer Book Archive